Primary Recipient

NORTHSHORE UNIVERSITY HEALTHSYSTEM RESEARCH INSTITUTE

Amount

$211,549.00

Award Date

8/25/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Hypothesis: The endogenous TLR-ligand SP-A may act as an anti-inflammatory or pro-inflammatory ligand in pregnancy, depending on site of action (extrauterine vs. intrauterine vs. intraamniotic, respectively). Specific Aims (listed as sub-Aims of the ori

Vendors Connected to Award

Vendor	Role	Amount
Thermo Electron North America	Primary vendor	$6,186.00
Cardinal/Allegiance	Primary vendor	$627.04
NorthShore Research Institute	Primary vendor	$14,457.61
Invitrogen	Primary vendor	$3,505.57
USA Scientific	Primary vendor	$1,208.50
Sigma Aldrich Inc	Primary vendor	$643.50
Yana Filipovich	Primary vendor	$741.59
Xiaowu Qu	Primary vendor	$2,167.58
New England Peptide	Primary vendor	$971.00
Qiagen	Primary vendor	$3,580.15
Harlan Laboratories	Primary vendor	$510.00
Jackson Labs	Primary vendor	$1,192.60
Enzo Life Sciences	Primary vendor	$2,340.00
Fisher Scientific	Primary vendor	$3,164.75
Applied Biosystem	Primary vendor	$618.87
Bio-Rad Laboratories	Primary vendor	$497.77
VWR International	Primary vendor	$8,491.35